Sc.D. 1974, Massachusetts Institute of Technology
"Our work is at the interface of biotechnology and materials science. A major focus is the study and development of polymers to deliver drugs, particularly genetically engineered proteins and DNA, continuously at controlled rates for prolonged periods of time. Our interest in drug delivery systems has extended to selective drug or substance removal systems that may circumvent toxicity. In addition, we are developing drugs that specifically inhibit the process of neovascularization that is critical to several disease processes without interfering with existing blood vessels. Finally, we have been involved in creating approaches to engineer new tissues. In particular, we are synthesizing new biodegradable polymer systems to be used in mammalian cell transplants to create liver, cartilage, and nerves, and are developing bioreactors for these purposes."
Dr. Langer is the Koch Institute Professor at MIT. He received his bachelor's degree from Cornell University in chemical engineering and earned his Sc.D. in chemical engineering from MIT in 1974. Dr. Langer has written over 1,175 articles and has approximately 800 issued and pending patents worldwide, which have been licensed or sublicensed to over 220 pharmaceutical, chemical, biotechnology, and medical device companies. He is the most cited engineer in history. Additionally, Dr. Langer has served as a member of the FDA’s SCIENCE Board from 1995-2002 and as its Chairman from 1999-2002. In 1989, Dr. Langer was elected to the Institute of Medicine of the National Academy of Sciences, and in 1992 he was elected to both the National Academy of Engineering and to the National Academy of Sciences. He has received over 200 major awards including the 2006 United States National Medal of Science, the Charles Stark Draper Prize, the 2008 Millennium Prize, the 2012 Priestley Medal and the Gairdner Foundation International Award. Forbes (1999) and BioWorld (1990) have named Dr. Langer as one of the 25 most important individuals in biotechnology in the world, Discover Magazine (2002) named him as one of the 20 most important people in this area, and Forbes (2002) selected him as one of the 15 innovators worldwide who will reinvent our future. Both TIME and CNN (2001) named Dr. Langer as one of the 100 most important people in America and one of the 18 top people in science or medicine in America.